chromomycin-a3 and Melanoma

chromomycin-a3 has been researched along with Melanoma* in 3 studies

Other Studies

3 other study(ies) available for chromomycin-a3 and Melanoma

ArticleYear
Chromomycin A2 induces autophagy in melanoma cells.
    Marine drugs, 2014, Dec-04, Volume: 12, Issue:12

    The present study highlights the biological effects of chromomycin A2 toward metastatic melanoma cells in culture. Besides chromomycin A2, chromomycin A3 and demethylchromomycin A2 were also identified from the extract derived from Streptomyces sp., recovered from Paracuru Beach, located in the northeast region of Brazil. The cytotoxic activity of chromomycin A2 was evaluated across a panel of human tumor cell lines, which found IC50 values in the nM-range for exposures of 48 and 72 h. MALME-3M, a metastatic melanoma cell line, showed the highest sensitivity to chromomycin A2 after 48h incubation, and was chosen as a model to investigate this potent cytotoxic effect. Treatment with chromomycin A2 at 30 nM reduced cell proliferation, but had no significant effect upon cell viability. Additionally, chromomycin A2 induced accumulation of cells in G0/G1 phase of the cell cycle, with consequent reduction of S and G2/M and unbalanced expression of cyclins. Chromomycin A2 treated cells depicted several cellular fragments resembling autophagosomes and increased expression of proteins LC3-A and LC3-B. Moreover, exposure to chromomycin A2 also induced the appearance of acidic vacuolar organelles in treated cells. These features combined are suggestive of the induction of autophagy promoted by chromomycin A2, a feature not previously described for chromomycins.

    Topics: Autophagy; Brazil; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromomycin A3; Chromomycins; HCT116 Cells; HL-60 Cells; Humans; Melanoma; Microtubule-Associated Proteins; Plicamycin; Streptomyces

2014
Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
    Biochemical pharmacology, 1994, Mar-02, Volume: 47, Issue:5

    To study the relationship between the structure of minor groove ligands and their affinity for specific DNA sequences that regulate gene transcription, three analogues of the A-T-specific DNA minor groove ligands Hoechst 33258 and Hoechst 33342 were synthesized with 5, 8 or 12 carbons in an aliphatic chain attached to the phenolic oxygen of the molecule. There was a striking bimodal relationship between toxicity to HeLa cells and the lipophilicity of the five analogues, toxicity being low for the compounds with a free hydroxyl (Hoechst 33258) or a 12-carbon substituent, yet high for the 5-carbon analogue. Selective killing of human melanoma cells compared with normal fibroblasts was observed for the Hoechst analogue with a 12-carbon chain attached. Hoechst 33258 itself was selectively toxic for the MM96E melanoma cell line compared with other cell lines, induced a highly dendritic morphology, increased tyrosinase activity and tyrosinase mRNA but decreased the level of gp75 (TRP-1) mRNA; message for a third pigment gene, Pmel-17, was unchanged. Tyrosinase activity was decreased in the resistant A2058 melanoma cell line and transcription was affected to a lesser extent than in MM96E. Expression of gp75 protein and two intermediate filament proteins was inhibited by Hoechst 33258 in MM96E cells. There was no major difference in the amount of 125I-Hoechst 33258 taken up by sensitive and resistant cells. Of the five derivatives studied, the parent drug Hoechst 33258 and the 2-carbon analogue (Hoechst 33342) were found to have the most inhibitory effect on affinity of octamer binding proteins for the ATGCAAAT consensus sequence found in the promoter region of certain genes associated with proliferation and differentiation. In contrast to Distamycin A (also an A-T-specific minor groove ligand), Hoechst 33258 displaced proteins already bound to the octamer motif. The G-C ligand chromomycin A3 exhibited a different spectrum of cell toxicity and tyrosinase stimulation compared with Hoechst 33258. Chromomycin A3 but not Hoechst 33258, strongly inhibited the zinc-dependent transcriptional activity of the sheep metallothionein-Ia promoter in reporter gene assays of transfected cells. Since the six metal-responsive elements of the promoter are GC-rich, this provides independent evidence for the sequence-specificity of transcriptional inactivation by one of these drugs in melanoma cells. Overall, the results suggest that Hoechst 33258 acts by inhibiting the transcriptio

    Topics: Base Sequence; Benzimidazoles; Bisbenzimidazole; Cell Cycle; Cell Differentiation; Cell Survival; Chromomycin A3; DNA-Binding Proteins; DNA, Neoplasm; HeLa Cells; Humans; Melanoma; Membrane Glycoproteins; Molecular Sequence Data; Monophenol Monooxygenase; Oxidoreductases; Promoter Regions, Genetic; Proteins; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured

1994
Malignant melanoma with adjacent intraepidermal proliferation.
    The Tohoku journal of experimental medicine, 1974, Volume: 114, Issue:2

    Topics: Adult; Chromomycin A3; Ethnicity; Female; Heel; Humans; Hydroxyurea; Lentigo; Lip Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanocytes; Melanoma; Middle Aged; Mitomycins; Prognosis; Skin Neoplasms; Thumb; Vulvar Neoplasms

1974